CD73-IN-22
CD73-IN-22 (Compound HX-6) is a non-nucleoside CD73 inhibitor with an IC50 of 0.07 μM. When radiolabeled with 68Ga, CD73-IN-22 acts as a PET radiotracer for detecting CD73 expression. When radiolabeled with 177Lu, CD73-IN-22 exhibits anticancer activity against colorectal adenocarcinoma. CD73-IN-22 is applicable to research related to colon adenocarcinoma and breast cancer.
For research use only. We do not sell to patients.
- Formula: C43H45FN12O9
- Molecular Weight:892.89
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Radionuclide-Drug Conjugates (RDCs) Isoforms
More
Biological Activity
IC50: 0.07 μM (CD73)[1]
Chemical Information
-
Molecular Weight 892.89
-
Formula C43H45FN12O9
-
SMILES
OC(CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(C(CCC(N2N=CC3=C2C=C(N4C(C=C(C5=CC=NN5CC6=CC=C(C#N)C=C6)C=C7F)=C7N=N4)C=C3)=O)C(O)=O)CC1)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)